NEW YORK (GenomeWeb News) – The Biomedical Diagnostics Institute in Dublin, Ireland, said today that it has purchased one of Biacore’s label-free protein interaction systems for its diagnostics research programs.

BDI said it will use Biacore’s A100 system to help develop diagnostics for cardiac conditions, cancer, blood coagulation and monitoring, and for mastitis in cattle.

The institute used funds from Science Foundation Ireland to buy the system, and said it is the first academic research institute in Europe to install one.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.